The availability of specific markers of myocardial damage has focused atten
tion on the decision limits to be used in clinical practice. These markers
can be employed in the diagnosis of myocardial infarction and risk stratifi
cation in patients with acute coronary syndromes but no infarction. The mea
surement of troponin I was undertaken in two 60 patient cohorts with these
disease classifications. The best decision level for patients with acute my
ocardial infarction was found to be 3.1 mug/l; for the detection of minimal
myocardial damage the cut-off was equal to the detection limit of the meth
od (0.2 mug/l).